These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15765009)

  • 1. [Mutations of peroxisome proliferator-activated receptor gamma (PPARgamma): clinical implications].
    Gacka M; Adamiec R
    Postepy Hig Med Dosw (Online); 2004; 58():483-9. PubMed ID: 15765009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of PPARgamma2 polymorphism with obesity and metabolic syndrome in postmenopausal Polish women.
    Milewicz A; Tworowska-Bardziñska U; Dunajska K; Jêdrzejuk D; Lwow F
    Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):628-32. PubMed ID: 19609844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
    Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
    Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of genetic variation of PPARgamma in humans.
    Meirhaeghe A; Amouyel P
    Mol Genet Metab; 2004; 83(1-2):93-102. PubMed ID: 15464424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of peroxisome proliferator-activated receptor (PPAR-γ) mRNA expression with Pro12Ala polymorphism in obesity.
    Berhouma R; Kouidhi S; Ammar M; Abid H; Ennafaa H; Benammar-Elgaaied A
    Biochem Genet; 2013 Apr; 51(3-4):256-63. PubMed ID: 23315125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of candidate genes in Polish families with obesity.
    Malczewska-Malec M; Wybranska I; Leszczynska-Golabek I; Partyka L; Hartwich J; Jabrocka A; Kiec-Wilk B; Kwasniak M; Motyka M; Dembinska-Kiec A
    Clin Chem Lab Med; 2004 May; 42(5):487-93. PubMed ID: 15202783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Cakir N; Arslan M
    Gynecol Endocrinol; 2006 Jun; 22(6):336-42. PubMed ID: 16785159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene variants on metabolic syndrome traits.
    Bozina T; Simić I; Lovrić J; Pećin I; Jelaković B; Sertić J; Reiner Z
    Coll Antropol; 2013 Sep; 37(3):801-8. PubMed ID: 24308220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
    Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
    Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individuals.
    Montagnana M; Fava C; Nilsson PM; Engström G; Hedblad B; Lippi G; Minuz P; Berglund G; Melander O
    Diabet Med; 2008 Aug; 25(8):902-8. PubMed ID: 18959602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes.
    Cai J; Shi X; Wang H; Fan J; Feng Y; Lin X; Yang J; Cui Q; Tang C; Xu G; Geng B
    Biochim Biophys Acta; 2016 May; 1861(5):419-29. PubMed ID: 26946260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of genetic risk factors confers increased risk for metabolic syndrome: the role of peroxisome proliferator-activated receptor γ.
    Božina T; Sertić J; Lovrić J; Jelaković B; Šimić I; Reiner Ž
    Genet Test Mol Biomarkers; 2014 Jan; 18(1):32-40. PubMed ID: 24200052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the relationship between PPAR-gamma 2 gene variants and severe insulin resistance in obese patients with impaired glucose tolerance.
    Blüher M; Paschke R
    Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):85-90. PubMed ID: 12746759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is obesity associated with a polymorphism Pro12Ala and Pro115Gln in PPARgamma gene?].
    Bidzińska B; Demissie M; Tworowska U; Slezak R; Dobosz T; Milewicz A
    Pol Merkur Lekarski; 2004 May; 16(95):434-7. PubMed ID: 15518421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
    Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH
    Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophy.
    Lüdtke A; Buettner J; Wu W; Muchir A; Schroeter A; Zinn-Justin S; Spuler S; Schmidt HH; Worman HJ
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2248-55. PubMed ID: 17356052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma and immunological processes in patients with type 2 diabetes and insulin resistance].
    Gacka M; Bednarska-Chabowska D; Dobosz T; Szymaniec S; Jakobsche U; Lebioda A; Adamiec R
    Przegl Lek; 2007; 64(6):393-7. PubMed ID: 18159845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.